Cheaper cost of stem cell treatment attracts more patients to Asia
Increased restrictions on funding of stem cell research in the United States has forced many Americans to seek international medical treatment for their various ailments in developing countries. According to a website www.placidway.com : "The potential cost of stem cell therapies in the U.S. may be prohibitive expense, which encourages those hoping and seeking cures for illnesses, injuries and disease ;processes to travel to China, Thailand, Japan, Europe, and India, among others." The website said the cost of therapies is determined according to geographic location of treatment facilities as well as the injury, illness or disease being treated. "Because such treatments have not yet been approved in the U.S., medical travelers are cautioned to do their homework and study human stem cell therapy, treatments and protocols and examine the history as well as case studies in foreign destinations." To date, the U.S. has approved funding for Phase I clinical trials